Benralizumab Outperforms Steroids in Treating Asthma and COPD Flare-Ups
Benralizumab injection improved respiratory symptoms within 28 days and reduced treatment failures by fourfold after 90 days compared to standard steroid therapy.
Benralizumab injection improved respiratory symptoms within 28 days and reduced treatment failures by fourfold after 90 days compared to standard steroid therapy.
Benralizumab injection improved respiratory symptoms within 28 days and reduced treatment failures by fourfold after 90 days compared to standard steroid therapy.
Read MoreThe NCQA’s white paper outlines the realities of asthma care in the United States and the policy and clinical interventions that may provide improvements.
Read MoreA Canadian study found that 72% of patients with uncontrolled severe asthma were not on available biologic therapy, and 40% had four or more oral corticosteroid courses.
Read MoreThe 12-month study will assess how a digital platform designed for asthma management impacts symptom control, medication adherence, and healthcare utilization in patients with moderate to severe asthma.
Read MoreMany children with recurrent wheezing have undetected lung infections that may be more effectively treated with antivirals instead of commonly prescribed steroids.
Read MoreDespite updated guidelines, only 14.5% of adults with moderate to severe asthma are prescribed the SMART combination inhaler regimen.Â
Read MoreTwo practice parameters from the Joint Task Force for Practice Parameters offer evidence-based recommendations for the diagnosis and management of anaphylaxis and atopic dermatitis in pediatric and adult patients.Â
Read MoreIn this 2023 update of RT’s pharmacological treatment of respiratory disorders, the most commonly administered classes of pulmonary medications are reviewed.
Read MorePatients who regularly use intranasal corticosteroids were less likely to develop severe COVID-19-related disease, including a 20 to 25% lower risk of hospitalization, ICU admission and mortality.
Read MoreAsthmatic children are less likely to respond to inhaled steroid medication if they are overweight or obese, and this leads to more frequent asthma attacks, according to research at the virtual ERS Congress 2021.
Read MoreSteroid treatment in intubated patients with angioedema had no effect on length of time spent in intensive care unit, new research shows.
Read MoreThe results of the ACTT-1 trial, which looked at the effectiveness of remdesivir as a treatment for COVID-19, have been published.
Read MoreNearly 3-in-4 of emerging adults with asthma do not adhere to their prescribed inhaled corticosteroid therapy, according to a study published in the Journal of Asthma.
Read MoreA new ERJ analysis found inhaled corticosteroids may also reduce COPD patients’ risk of lung cancer by as much as 30%.
Read MoreThe use of monoclonal antibodies as an alternative to oral corticosteroids could improve quality of life in patients with severe asthma, according to Asthma UK.
Read MoreLevels of fractionated exhaled of nitric oxide (FeNO) can indicate whether patients with unexplained coughs need treatment with inhaled corticosteroids.
Read MoreThe US FDA has approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne muscular dystrophy (DMD).
Read MoreCritically ill patients receiving steroids in a hospital’s ICU are significantly more likely to develop delirium, according to researchers from Johns Hopkins. Minimizing the use of steroids could reduce delirium in the ICU, they suggested.
Read MoreIn adults with chronic sinus disease and poorly controlled asthma, the use of nasal steroids only improved nasal symptoms but had no effect on asthma control. Results were presented at the American Thoracic Society Annual Conference.
Read MoreA 5-day treatment of systemic glucocorticoid therapy was not less effective than a 14-day treatment for COPD patients in the ED, in terms of re-exacerbation within 6 months, according to a study by Swiss researchers.
Read MoreSevere asthma greatly enhances the risk of pulmonary embolism, particularly if chronic corticosteroids are used.
Read MoreRespiratory therapists are often some of the few resources to offer expert help in finding alternative respiratory medications for patients who experience side effects.
Read More